Table 1

Demographic and clinical characteristics*

CharacteristiciTBS (n = 15)5 Hz rTMS (n = 11)Sham (n = 15)p value
Age, yr60.13 ± 14.157.45 ± 12.356.23 ± 120.77
M/F, n11/49/213/20.65
Education, yr11.27 ± 5.414 ± 2.813.64 ± 1.90.56
Poststroke duration, mo18.47 ± 20.2133.27 ± 26.438 ± 7.90.016
Ischemic stroke/hemorrhagic stroke, n7/83/810/50.14
Lesion site (cortex + subcortical, or subcortical), n11/410/112/30.31
Anomic aphasia, n5< 5< 50.86
Comorbidities, n
 Hypertension9< 5100.29
 Diabetes mellitus5< 5< 50.23
 Dyslipidemia< 50< 50.43
RBANS scores
 Total73.7 ± 12.269.1 ± 10.965.3 ± 16.10.19
 Immediate memory73.1 ± 16.669.2 ± 20.061.3 ± 20.00.25
 Visuospatial ability98.9 ± 13.487.0 ± 13.982.9 ± 15.60.17
 Language70.1 ± 14.076.3 ± 4.863.3 ± 18.10.25
 Attention77.5 ± 19.170.1 ± 18.976.1 ± 20.80.52
 Delayed memory79.5 ± 18.875.1 ± 21.176.1 ± 20.80.86
Beck Depression Inventory score14.5 ± 10.013.0 ± 13.29.2 ± 8.20.27
  • F = female; iTBS = intermittent theta burst stimulation; M = male; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; rTMS = repetitive transcranial magnetic stimulation.

  • * Data are mean ± standard deviation unless otherwise specified. Populations of fewer than 5 people have been rounded to protect participant privacy.

  • One-way analysis of variance for continuous data and a χ2 test, with significance levels set at p < 0.05. Post hoc analyses revealed significantly longer disease duration in the 5 Hz rTMS group at baseline (p = 0.016), which we used as an explanatory variable for intergroup comparison. Bonferroni correction: iTBS v. 5 Hz rTMS, Z = −3.776, p = 0.001.